CooleyREG Talks (EU): New European Commission, New Economic Regulation for the EU and Beyond
New European Commission – What Biotech and Medtech Companies Need to Know
Event summary
A new European Commission is gearing up to take office. The agenda for the five years ahead was unveiled, and 27 commissioners designated by the European Union’s Member States. Join us to hear members of our CooleyREG team share insider perspectives on what matters most for your next deals, development and launch projects.
Session 3: New European Commission – What Biotech and Medtech Companies Need to Know
10:00 am PDT / 1:00 pm EDT / 5:00 pm GMT / 6:00 pm CET
What initiatives are geared to drive biotech and medtech innovation and to accelerate routes to market in the EU? This session will cover topics such as pharma and medtech regulation, medical product initiatives, preventive health initiatives, life sciences and data, and competition law enforcement.
For more information, please email Elena-Alina Rapotan.
EU programming
This webinar series will discuss the implications of the new European Commission on the EU and beyond. Cooley lawyers will address what matters most for dealmaking as well as insights for tech-driven companies across industries.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.